All Stories

  1. The current status of immunobased therapies for metastatic renal-cell carcinoma

    Article • ImmunoTargets and Therapy, December 2017, Dove Medical Press

    Dr Thomas S Griffith

  2. TRAIL deletion prevents liver inflammation but not adipose tissue inflammation during murine diet-induced obesity

    Article • Hepatology Communications, July 2017, Wiley

    Dr Thomas S Griffith, Warda Salim

  3. Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease

    Article • Experimental Biology and Medicine, September 2016, SAGE Publications

    Dr Thomas S Griffith

  4. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma

    Article • FEBS Journal, October 2015, Wiley

    Dr Thomas S Griffith

  5. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptotic pathways in cancer immunosurveillance: molecular mechanisms and prospects for therapy

    Article • Research and Reports in Biochemistry, December 2014, Dove Medical Press

    Dr Thomas S Griffith